SECsense Logo

Royalty Pharma plc 8-K Report: Key Insights & Financial Updates

$RPRX
Form 8-K
Filed on: 2025-01-10
Source
Royalty Pharma plc 8-K Report: Key Insights & Financial Updates

The provided section of the financial report contains several key pieces of information regarding Royalty Pharma plc. Here are the extracted insights:

  1. Company Identification:
  • Name: Royalty Pharma plc
  • CIK: 0001802768
  • IRS Employer Identification Number: 98-1535773
  • Address: 110 East 59th Street, New York, NY 10022
  • Phone Number: (212) 883-0200
  1. Security Information:
  • Class of Shares: Class A Ordinary Shares
  • Par Value: $0.0001 per share
  • Ticker Symbol: RPRX
  • Exchange: NASDAQ
  1. Filing Type:
  • Form Type: 8-K (used to report unscheduled material events or corporate changes)
  1. Filing Date:
  • Date of Report: January 10, 2025
  1. Reporting Period:
  • Start Date: January 10, 2025
  • End Date: January 10, 2025
  1. XBRL Information:
  • The filing utilizes XBRL (eXtensible Business Reporting Language) for tagging financial data, which allows for improved accessibility and analysis of the data.

Summary

This financial report is a Form 8-K filed by Royalty Pharma plc, indicating a significant event or change as of January 10, 2025. The information includes essential company details, share characteristics, and the use of XBRL, which enhances the data's usability for investors and analysts.